Trade Summary

6 days ago, Klein Matthew B., serving as Dir at ClearPoint Neuro, Inc. (CLPT), sold 16,000 shares at $11.59 per share, for a total transaction value of $185,440.00. Following this transaction, Klein Matthew B. now holds 46,935 shares of CLPT.

This sale represents a 25.42% decrease in Klein Matthew B.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 21, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 26, 2026 at 4:30 PM ET, 5 days after the trade was made.

ClearPoint Neuro, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.